| Filed On | Filing |
|---|---|
| 08 Apr 2025 |
Form 4/A: Rouan Sarah Kathryn, Director
Bought 1,240 shares ($29.9K) |
| 28 Aug 2020 |
Form 4/A: Ligand Pharmaceuticals Inc, 10% owner
Sold 148,700 shares ($1.21M) |
Loading...